Alkermes plc (ALKS) vs Ionis Pharmaceuticals, Inc. (IONS)
A side-by-side comparison of Alkermes plc and Ionis Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALKS
Alkermes plc
$41.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
IONS
Ionis Pharmaceuticals, Inc.
$44.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALKS vs IONS
growth of $100 · dividends reinvested · last 10yALKS +1.1% (+0.1%/yr)IONS +50.0% (+4.1%/yr)IONS compounded faster over this window
ALKS IONS
ALKS vs IONS: by the numbers
- •IONS is the larger company ($7.31B vs $6.99B market cap).
- •ALKS is profitable (3.97% net margin) while IONS runs a net loss (-64.64%).
- •ALKS grew revenue faster over the past five years (8.68% vs 4.91% CAGR).
Metrics side by side
Valuation
| Metric | ALKS | IONS |
|---|---|---|
| P/E ratio | 108.75 | N/A |
| P/S ratio | 4.19 | 8.37 |
| P/B ratio | 3.86 | 16.63 |
| EV / EBITDA | 44.98 | 2.21 |
| FCF yield | 3.17% | N/A |
Profitability
| Metric | ALKS | IONS |
|---|---|---|
| Gross margin | 84.56% | 98.16% |
| Operating margin | 17.21% | -40.47% |
| Net margin | 3.97% | -64.64% |
| ROE | 3.66% | -128.44% |
| ROIC | 2.12% | -20.37% |
Growth (annualized)
| Metric | ALKS | IONS |
|---|---|---|
| Revenue CAGR (5Y) | 8.68% | 4.91% |
| FCF CAGR (5Y) | 20.00% | N/A |
| Total return CAGR (5Y) | 6.73% | 5.82% |
Frequently asked
- Which has grown faster, ALKS or IONS?
- Over the past five years, ALKS grew revenue faster — ALKS at a 8.68% CAGR versus IONS at 4.91%.
- Is ALKS or IONS more profitable?
- ALKS runs the higher net margin — ALKS at 3.97% versus IONS at -64.64%.
- How have ALKS and IONS total returns compared?
- Over the past 10 years, ALKS delivered -0.82% and IONS delivered 1.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.